The Malaysian Debt Ventures Bhd (MDV) is expecting RM973 million worth of deals this year for the information communication technology (ICT), biotechnology and green technology industries, says Zubir Ansori Yahaya, Managing Director and Chief Executive Officer of MDV.
Out of the RM973 million target funding approval for this year, RM450 million has been approved by the Ministry of Finance (MOF), he said at a press conference today on the BioMalaysia 2012 Conference to be held here this November 5-7.
Meanwhile, Datuk Dr. Mohd Nazlee Kamal, Chief Executive Officer of Malaysian Biotechnology Corporation Sdn Bhd, said Malaysia’s biotechnology industry is expected to contribute four per cent to the country’s Gross Domestic Product (GDP) and 10 per cent to the regional biotechnology market by the end of phase two.
The National Biotechnology Policy (NBP) is set to attract RM9 billion worth of investment in the second phase from 2011 until 2015.
The biotechnology industry in Malaysia has marked impressive and encouraging achievements especially during the first phase of the NBP.
Achievements set during the first phase are robust, whereby the industry has managed to attract RM5.4 billion worth of investments, acquired a total of RM13.5 billion in revenue, provided 54,776 jobs opportunities and contributed 2.2 per cent towards GDP.
The BioMalaysia 2012 Conference meanwhile will address the latest innovation and commercialisation issues in bioeconomy including strategies, value chains, impact and opportunities. About 400 delegates and 37 speakers will be joining the event.
The BioMalaysia Exhibition, to be held in conjunction with the event, will feature more than 200 local and international exhibitors. It is expected to attract about 10,000 visitors expected this year.